Potent Antibacterial Nanoparticles against Biofilm and Intracellular Bacteria

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Mu, Haibo ^a   Tang, Jiangjiang ^a   Liu, Qianjin ^a   Sun, Chunli ^a   Wang, Tingting ^a   Duan, Jinyou ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GOLD; METAL NANOPARTICLE;

ADSORPTION; ANIMAL; BACTERIUM; BIOFILM; CELL LINE; CHEMISTRY; DRUG EFFECTS; MACROPHAGE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOUSE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; ULTRASTRUCTURE;

ADSORPTION; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BIOFILMS; CELL LINE; GOLD; MACROPHAGES; METAL NANOPARTICLES; MICE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84953312109     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18877     Document Type: Article

References (32)

1. Lasa, I. Towards the identification of the common features of bacterial biofilm development. International Microbiology 9, 21-28 (2006).
2. Mittelman, M. W. Structure and Functional Characteristics of Bacterial Biofilms in Fluid Processing Operations. Journal of dairy science 81, 2760-2764 (1998).
3. Van Houdt, R., Michiels, C. W. Biofilm formation and the food industry, a focus on the bacterial outer surface. Journal of applied microbiology 109, 1117-1131 (2010).
4. Flemming, H.-C., Wingender, J. The biofilm matrix. Nature Reviews Microbiology 8, 623-633 (2010).
5. Donlan, R. M., Costerton, J. W. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms. Clinical microbiology reviews 15, 167-193 (2002).
6. Parsek, M. R., Singh, P. K. Bacterial Biofilms: An Emerging Link to Disease Pathogenesis. Annual Review of Microbiology 57, 677-701 (2003).
7. Davies, D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2, 114-122 (2003).
8. Gómez, M. I., Prince, A. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Current Opinion in Pharmacology 7, 244-251 (2007).
9. Mu, H. et al. Chitosan improves anti-biofilm efficacy of gentamicin through facilitating antibiotic penetration. International Journal of Molecular Sciences 15, 22296-22308 (2014).
10. Worthington, R. J., Richards, J. J., Melander, C. Small molecule control of bacterial biofilms. Organic & Biomolecular Chemistry 10, 7457-7474 (2012).
11. Zhang, A. et al. Chitosan Coupling Makes Microbial Biofilms Susceptible to Antibiotics. Sci. Rep. 3 (2013).
12. Du, J. et al. Improved Biofilm Antimicrobial Activity of Polyethylene Glycol Conjugated Tobramycin Compared to Tobramycin in Pseudomonas aeruginosa Biofilms. Molecular Pharmaceutics 12, 1544-1553 (2015).
13. Flores, C. Y. et al. Citrate-Capped Silver Nanoparticles Showing Good Bactericidal Effect against Both Planktonic and Sessile Bacteria and a Low Cytotoxicity to Osteoblastic Cells. ACS Appl Mater Interfaces 5, 3149-3159 (2013).
14. Adhikari, M. D., Goswami, S., Panda, B. R., Chattopadhyay, A., Ramesh, A. Membrane-Directed High Bactericidal Activity of (Gold Nanoparticle)-Polythiophene Composite for Niche Applications Against Pathogenic Bacteria. Advanced Healthcare Materials 2, 599-606 (2013).
15. Slomberg, D. L. et al. Role of Size and Shape on Biofilm Eradication for Nitric Oxide-Releasing Silica Nanoparticles. ACS Appl Mater Interfaces 5, 9322-9329 (2013).
16. Goswami, S., Thiyagarajan, D., Das, G., Ramesh, A. Biocompatible Nanocarrier Fortified with a Dipyridinium-Based Amphiphile for Eradication of Biofilm. ACS Appl Mater Interfaces 6, 16384-16394 (2014).
17. Baelo, A. et al. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections. J Control Release 209, 150-158 (2015).
18. Joller, N. et al. Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting. Proc Natl Acad Sci USA 107, 20441-20446 (2010).
19. Ray, K., Marteyn, B., Sansonetti, P. J., Tang, C. M. Life on the inside: the intracellular lifestyle of cytosolic bacteria. Nature Reviews Microbiology 7, 333-340 (2009).
20. Butler, M. S., Cooper, M. A. Antibiotics in the clinical pipeline in 2011. The Journal of antibiotics 64, 413-425 (2011).
21. Abed, N., Couvreur, P. Nanocarriers for antibiotics: A promising solution to treat intracellular bacterial infections. International journal of antimicrobial agents 43, 485-496 (2014).
22. Imbuluzqueta, E., Gamazo, C., Ariza, J., Blanco-Prieto, M. J. Drug delivery systems for potential treatment of intracellular bacterial infections. Frontiers in Bioscience-Landmark 15, 397-417 (2010).
23. Zhao, L. et al. Polyglycerol-coated nanodiamond as a macrophage-evading platform for selective drug delivery in cancer cells. Biomaterials 35, 5393-5406 (2014).
24. Kurtz-Chalot, A. et al. Quantification of nanoparticle endocytosis based on double fluorescent pH-sensitive nanoparticles. Biomed Microdevices 17, 1-12 (2015).
25. Mackiewicz, M. R., Ayres, B. R., Reed, S. M. Reversible, reagentless solubility changes in phosphatidylcholine-stabilized gold nanoparticles. Nanotechnology 19, 115607 (2008).
26. Burygin, G. et al. On the enhanced antibacterial activity of antibiotics mixed with gold nanoparticles. Nanoscale research letters 4, 794-801 (2009).
27. Xu, Q., Du, S., Li, H., Hu, X. Y. Determination of acetamiprid by a colorimetric method based on the aggregation of gold nanoparticles. Microchimica Acta 173, 323-329 (2011).
28. Birmingham, C. L. et al. Listeriolysin O allows Listeria monocytogenes replication in macrophage vacuoles. Nature 451, 350-354 (2008).
29. Miao, E. A., Ernst, R. K., Dors, M., Mao, D. P., Aderem, A. Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proceedings of the National Academy of Sciences 105, 2562-2567 (2008).
30. Szoka, F., Papahadjopoulos, D. Comparative Properties and Methods of Preparation of Lipid Vesicles (Liposomes). Annual Review of Biophysics and Bioengineering 9, 467-508 (1980).
31. Coradeghini, R. et al. Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts. Toxicology letters 217, 205-216 (2013).
32. Mu, H., Zhang, A., Zhang, L., Niu, H., Duan, J. Inhibitory effects of chitosan in combination with antibiotics on Listeria monocytogenes biofilm. Food Control 38, 215-220 (2014).